Home
Conditions
Merkel Cell Carcinoma

Clinical trial condition

Merkel Cell Carcinoma

Explore clinical trials studying Merkel Cell Carcinoma. Study availability and eligibility vary by location and protocol.

68 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Merkel Cell Carcinoma trial results

Recruiting

Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer

NCT05583708

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations: University of Iowa Hospitals and Clinics Iowa City, Iowa, United States

Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States

University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details

Recruiting

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

NCT06753136

Conditions: Abdominal and/or Peritoneal Localizations, Adenocarcinoma, Carcinoma, +36 more
Locations: Istituto Oncologico Veneto Padova, Italy

View Trial Details

Recruiting

EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers

NCT06223659

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +22 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma

NCT05496036

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations: Penn Medicine Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma

NCT06151236

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations: Melanoma Institute Australia Wollstonecraft, New South Wales, Australia

View Trial Details

Recruiting

TIL Therapy in cSCC and MCC

NCT07288073

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +21 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

NCT05859074

Conditions: Adenocarcinoma, Adenocarcinoma, Sebaceous, Adnexal Carcinoma, +58 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States

View Trial Details

Recruiting

Personalised Immunotherapy Platform

NCT06536257

Conditions: Adenocarcinoma, Basal Cell Carcinoma, Carcinoma, +25 more
Locations: Chris O'Brien Lifehouse Sydney, New South Wales, Australia

Melanoma Institute Australia Sydney, New South Wales, Australia

Westmead Hospital Sydney, New South Wales, Australia

View Trial Details

Recruiting

A Beta-only IL-2 ImmunoTherapY Study

NCT05086692

Conditions: Acral Melanoma, Adenocarcinoma, Adenoma, +120 more
Locations: Sharp Memorial Hospital San Diego, California, United States

UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

Providence Saint John's Health Center Santa Monica, California, United States

Boca Raton Regional Hospital Boca Raton, Florida, United States

View all 27 locations

View Trial Details

Not Yet Recruiting

ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1

NCT07472322

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
Locations: University of Wisconsin-Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details

Merkel Cell Carcinoma

Merkel Cell Carcinoma trial results

Related conditions